MANDALA', Mario
MANDALA', Mario
DIPARTIMENTO DI MEDICINA E CHIRURGIA
40. Fuchs CS, Doi T, Jang RW, Muro K, Satoh T, Machado M, Sun W, Jalal SI, Shah MA, Metges JP, Garrido M, Golan T, Mandala M, Wainberg ZA, Catenacci DV, Ohtsu A, Shitara K, Geva R, Bleeker J, Ko AH, Ku G, Philip P, Enzinger PC, Bang YJ, Levitan D, Wang J, Rosales M, Dalal RP, Yoon HH
2018 Fuchs, Cs; Doi, T; Jang, Rw; Muro, K; Satoh, T; Machado, M; Sun, W; Jalal, Si; Shah, Ma; Metges, Jp; Garrido, M; Golan, T; Mandala', M; Wainberg, Za; Catenacci, Dv; Ohtsu, A; Shitara, K; Geva, R; Bleeker, J; Ko, Ah; Ku, G; Philip, P; Enzinger, Pc; Bang, Yj; Levitan, D; Wang, J; Rosales, M; Dalal, Rp; Yoon, Hh.
A case of severe pharyngeal-cervical-brachial syndrome induced by nivolumab and responding to infliximab therapy
2020 Indini, A; Sessa, M; Merelli, B; Foresti, C; Mandala', M
A case of sudden brain metastases progression after temporary targeted therapy discontinuation: when to regret a drug holiday
2021 Indini, Alice; Rijavec, Erika; Mandala', Mario; Castiglioni, Simona; Beltramo, Giancarlo; Grossi, Francesco
A prospective study on survival in cancer patients with and without venous thromboembolism.
2014 Agnelli, Giancarlo; Verso, Melina; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino', Lucio; Labianca, R.
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1
2001 Lissoni, P; Malugani, F; Bonfanti, A; Bucovec, R; Secondino, S; Brivio, F; Ferrari-Bravo, A; Ferrante, R; Vigoré, L; Rovelli, F; Mandala', M; Viviani, S; Fumagalli, L; Gardani, Gs.
Abrogation of the negative influence of opioids on IL-2 immunotherapy of renal cell cancer by melatonin
2000 Lissoni, P; Mandala', M; Brivio, F.
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial
2010 Mandala', M; Barni, S; Prins, M; Labianca, R; Tondini, C; Russo, L; Milesi, A; Cremonesi, M; Zaccanelli, M; Regonesi, C; Moro, C; Falanga, A.
Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling
2016 Wicki, A; Mandala', M; Massi, D; Taverna, D; Tang, H; Hemmings, Ba; Xue, G
Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study
2022 Mandala', M.; Rutkowski, P.; Galli, F.; Patuzzo, R.; De Giorgi, V.; Rulli, E.; Gianatti, A.; Valeri, B.; Merelli, B.; Szumera-Cieckiewicz, A.; Massi, D.; Maurichi, A.; Teterycz, P.; Santinami, M.
Acute dyspnea due to right phrenic palsy during infusional chemotherapy
2004 Mandala', M; Ciano, C; Ghilardi, M; Cremonesi, M; Cazzaniga, M; Barni, S.
Acute endocrine effects of interleukin-12 in cancer patients
1997 Lissoni, P; Rovelli, F; Rivolta, Mr; Frigerio, C; Mandala', M; Barni, S; Ardizzoia, A; Malugani, F; Tancini, G.
Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703
2000 De Pas, Tm; Mandala', M; Curigliano, G; Peccatori, F.
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
2017 Long, Gv; Hauschild, A; Santinami, M; Atkinson, V; Mandala', M; Chiarion-Sileni, V; Larkin, J; Nyakas, M; Dutriaux, C; Haydon, A; Robert, C; Mortier, L; Schachter, J; Schadendorf, D; Lesimple, T; Plummer, R; Ji, R; Zhang, P; Mookerjee, B; Legos, J; Kefford, R; Dummer, R; Kirkwood, Jm
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 triaL
2020 Dummer, R; Brase, Jc; Garrett, J; Campbell, Cd; Gasal, E; Squires, M; Gusenleitner, D; Santinami, M; Atkinson, V; Mandala', M; Chiarion-Sileni, V; Flaherty, K; Larkin, J; Robert, C; Kefford, R; Kirkwood, Jm; Hauschild, A; Schadendorf, D; Long, Gv
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
2021 Mandala, Mario; Larkin, James; Ascierto, Paolo Antonio; Del Vecchio, Michele; Gogas, Helen; Cowey, C Lance; Arance, Ana; Dalle, Stéphane; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Marquez, Ivan; Butler, Marcus O; Di Giacomo, Anna Maria; Lutzky, Jose; De La Cruz-Merino, Luis; Atkinson, Victoria; Arenberger, Petr; Hill, Andrew; Fecher, Leslie; Millward, Michael; Khushalani, Nikhil I; de Pril, Veerle; Lobo, Maurice; Weber, Jeffrey
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria
2022 Larkin, J.; Weber, J.; Del Vecchio, M.; Gogas, H.; Arance, A. M.; Dalle, S.; Cowey, C. L.; Schenker, M.; Grob, J. -J.; Chiarion-Sileni, V.; Marquez-Rodas, I.; Butler, M. O.; Di Giacomo, A. M.; Middleton, M. R.; De la Cruz-Merino, L.; Arenberger, P.; Atkinson, V.; Hill, A.; Fecher, L. A.; Millward, M.; Khushalani, N. I.; Queirolo, P.; Long, G. V.; Lobo, M.; Askelson, M.; Ascierto, P. A.; Mandala', M.
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
2017 Weber, J; Mandala', M; Del Vecchio, M; Gogas, Hj; Arance, Am; Cowey, Cl; Dalle, S; Schenker, M; Chiarion-Sileni, V; Marquez-Rodas, I; Grob, Jj; Butler, Mo; Middleton, Mr; Maio, M; Atkinson, V; Queirolo, P; Gonzalez, R; Kudchadkar, Rr; Smylie, M; Meyer, N; Mortier, L; Atkins, Mb; Long, Gv; Bhatia, S; Lebbé, C; Rutkowski, P; Yokota, K; Yamazaki, N; Kim, Tm; de Pril, V; Sabater, J; Qureshi, A; Larkin, J; Ascierto, Pa; CheckMate 238, Collaborators.
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238
2023 Larkin, J.; Del Vecchio, M.; Mandala', M.; Gogas, H.; Fernandez, A. M. A.; Dalle, S.; Cowey, C. L.; Schenker, M.; Grob, J. -J.; Chiarion-Sileni, V.; Marquez-Rodas, I.; Butler, M. O.; Di Giacomo, A. M.; Middleton, M. R.; Lutzky, J.; de la Cruz-Merino, L.; Arenberger, P.; Atkinson, V.; Hill, A. G.; Fecher, L. A.; Millward, M.; Nathan, P. D.; Khushalani, N. I.; Queirolo, P.; Ritchings, C.; Lobo, M.; Askelson, M.; Tang, H.; Dolfi, S.; Ascierto, P. A.; Weber, J.
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
2020 Ascierto, Pa; Del Vecchio, M; Mandala', M; Gogas, H; Arance, Am; Dalle, S; Cowey, Cl; Schenker, M; Grob, Jj; Chiarion-Sileni, V; Márquez-Rodas, I; Butler, Mo; Maio, M; Middleton, Mr; de la Cruz-Merino, L; Arenberger, P; Atkinson, V; Hill, A; Fecher, La; Millward, M; Khushalani, Ni; Queirolo, P; Lobo, M; de Pril, V; Loffredo, J; Larkin, J; Weber, J
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
2018 Eggermont, Amm; Blank, Cu; Mandala', M; Long, Gv; Atkinson, V; Dalle, S; Haydon, A; Lichinitser, M; Khattak, A; Carlino, Ms; Sandhu, S; Larkin, J; Puig, S; Ascierto, Pa; Rutkowski, P; Schadendorf, D; Koornstra, R; Hernandez-Aya, L; Maio, M; van den Eertwegh, Ajm; Grob, Jj; Gutzmer, R; Jamal, R; Lorigan, P; Ibrahim, N; Marreaud, S; van Akkooi, Acj; Suciu, S; Robert, C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 40. Fuchs CS, Doi T, Jang RW, Muro K, Satoh T, Machado M, Sun W, Jalal SI, Shah MA, Metges JP, Garrido M, Golan T, Mandala M, Wainberg ZA, Catenacci DV, Ohtsu A, Shitara K, Geva R, Bleeker J, Ko AH, Ku G, Philip P, Enzinger PC, Bang YJ, Levitan D, Wang J, Rosales M, Dalal RP, Yoon HH | 2018 | Fuchs, Cs; Doi, T; Jang, Rw; Muro, K; Satoh, T; Machado, M; Sun, W; Jalal, Si; Shah, Ma; Metges, Jp; Garrido, M; Golan, T; Mandala', M; Wainberg, Za; Catenacci, Dv; Ohtsu, A; Shitara, K; Geva, R; Bleeker, J; Ko, Ah; Ku, G; Philip, P; Enzinger, Pc; Bang, Yj; Levitan, D; Wang, J; Rosales, M; Dalal, Rp; Yoon, Hh. | |
| A case of severe pharyngeal-cervical-brachial syndrome induced by nivolumab and responding to infliximab therapy | 2020 | Indini, A; Sessa, M; Merelli, B; Foresti, C; Mandala', M | |
| A case of sudden brain metastases progression after temporary targeted therapy discontinuation: when to regret a drug holiday | 2021 | Indini, Alice; Rijavec, Erika; Mandala', Mario; Castiglioni, Simona; Beltramo, Giancarlo; Grossi, Francesco | |
| A prospective study on survival in cancer patients with and without venous thromboembolism. | 2014 | Agnelli, Giancarlo; Verso, Melina; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino', Lucio; Labianca, R. | |
| Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1 | 2001 | Lissoni, P; Malugani, F; Bonfanti, A; Bucovec, R; Secondino, S; Brivio, F; Ferrari-Bravo, A; Ferrante, R; Vigoré, L; Rovelli, F; Mandala', M; Viviani, S; Fumagalli, L; Gardani, Gs. | |
| Abrogation of the negative influence of opioids on IL-2 immunotherapy of renal cell cancer by melatonin | 2000 | Lissoni, P; Mandala', M; Brivio, F. | |
| Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial | 2010 | Mandala', M; Barni, S; Prins, M; Labianca, R; Tondini, C; Russo, L; Milesi, A; Cremonesi, M; Zaccanelli, M; Regonesi, C; Moro, C; Falanga, A. | |
| Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling | 2016 | Wicki, A; Mandala', M; Massi, D; Taverna, D; Tang, H; Hemmings, Ba; Xue, G | |
| Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study | 2022 | Mandala', M.; Rutkowski, P.; Galli, F.; Patuzzo, R.; De Giorgi, V.; Rulli, E.; Gianatti, A.; Valeri, B.; Merelli, B.; Szumera-Cieckiewicz, A.; Massi, D.; Maurichi, A.; Teterycz, P.; Santinami, M. | |
| Acute dyspnea due to right phrenic palsy during infusional chemotherapy | 2004 | Mandala', M; Ciano, C; Ghilardi, M; Cremonesi, M; Cazzaniga, M; Barni, S. | |
| Acute endocrine effects of interleukin-12 in cancer patients | 1997 | Lissoni, P; Rovelli, F; Rivolta, Mr; Frigerio, C; Mandala', M; Barni, S; Ardizzoia, A; Malugani, F; Tancini, G. | |
| Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703 | 2000 | De Pas, Tm; Mandala', M; Curigliano, G; Peccatori, F. | |
| Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma | 2017 | Long, Gv; Hauschild, A; Santinami, M; Atkinson, V; Mandala', M; Chiarion-Sileni, V; Larkin, J; Nyakas, M; Dutriaux, C; Haydon, A; Robert, C; Mortier, L; Schachter, J; Schadendorf, D; Lesimple, T; Plummer, R; Ji, R; Zhang, P; Mookerjee, B; Legos, J; Kefford, R; Dummer, R; Kirkwood, Jm | |
| Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 triaL | 2020 | Dummer, R; Brase, Jc; Garrett, J; Campbell, Cd; Gasal, E; Squires, M; Gusenleitner, D; Santinami, M; Atkinson, V; Mandala', M; Chiarion-Sileni, V; Flaherty, K; Larkin, J; Robert, C; Kefford, R; Kirkwood, Jm; Hauschild, A; Schadendorf, D; Long, Gv | |
| Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival | 2021 | Mandala, Mario; Larkin, James; Ascierto, Paolo Antonio; Del Vecchio, Michele; Gogas, Helen; Cowey, C Lance; Arance, Ana; Dalle, Stéphane; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Marquez, Ivan; Butler, Marcus O; Di Giacomo, Anna Maria; Lutzky, Jose; De La Cruz-Merino, Luis; Atkinson, Victoria; Arenberger, Petr; Hill, Andrew; Fecher, Leslie; Millward, Michael; Khushalani, Nikhil I; de Pril, Veerle; Lobo, Maurice; Weber, Jeffrey | |
| Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria | 2022 | Larkin, J.; Weber, J.; Del Vecchio, M.; Gogas, H.; Arance, A. M.; Dalle, S.; Cowey, C. L.; Schenker, M.; Grob, J. -J.; Chiarion-Sileni, V.; Marquez-Rodas, I.; Butler, M. O.; Di Giacomo, A. M.; Middleton, M. R.; De la Cruz-Merino, L.; Arenberger, P.; Atkinson, V.; Hill, A.; Fecher, L. A.; Millward, M.; Khushalani, N. I.; Queirolo, P.; Long, G. V.; Lobo, M.; Askelson, M.; Ascierto, P. A.; Mandala', M. | |
| Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma | 2017 | Weber, J; Mandala', M; Del Vecchio, M; Gogas, Hj; Arance, Am; Cowey, Cl; Dalle, S; Schenker, M; Chiarion-Sileni, V; Marquez-Rodas, I; Grob, Jj; Butler, Mo; Middleton, Mr; Maio, M; Atkinson, V; Queirolo, P; Gonzalez, R; Kudchadkar, Rr; Smylie, M; Meyer, N; Mortier, L; Atkins, Mb; Long, Gv; Bhatia, S; Lebbé, C; Rutkowski, P; Yokota, K; Yamazaki, N; Kim, Tm; de Pril, V; Sabater, J; Qureshi, A; Larkin, J; Ascierto, Pa; CheckMate 238, Collaborators. | |
| Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238 | 2023 | Larkin, J.; Del Vecchio, M.; Mandala', M.; Gogas, H.; Fernandez, A. M. A.; Dalle, S.; Cowey, C. L.; Schenker, M.; Grob, J. -J.; Chiarion-Sileni, V.; Marquez-Rodas, I.; Butler, M. O.; Di Giacomo, A. M.; Middleton, M. R.; Lutzky, J.; de la Cruz-Merino, L.; Arenberger, P.; Atkinson, V.; Hill, A. G.; Fecher, L. A.; Millward, M.; Nathan, P. D.; Khushalani, N. I.; Queirolo, P.; Ritchings, C.; Lobo, M.; Askelson, M.; Tang, H.; Dolfi, S.; Ascierto, P. A.; Weber, J. | |
| Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial | 2020 | Ascierto, Pa; Del Vecchio, M; Mandala', M; Gogas, H; Arance, Am; Dalle, S; Cowey, Cl; Schenker, M; Grob, Jj; Chiarion-Sileni, V; Márquez-Rodas, I; Butler, Mo; Maio, M; Middleton, Mr; de la Cruz-Merino, L; Arenberger, P; Atkinson, V; Hill, A; Fecher, La; Millward, M; Khushalani, Ni; Queirolo, P; Lobo, M; de Pril, V; Loffredo, J; Larkin, J; Weber, J | |
| Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma | 2018 | Eggermont, Amm; Blank, Cu; Mandala', M; Long, Gv; Atkinson, V; Dalle, S; Haydon, A; Lichinitser, M; Khattak, A; Carlino, Ms; Sandhu, S; Larkin, J; Puig, S; Ascierto, Pa; Rutkowski, P; Schadendorf, D; Koornstra, R; Hernandez-Aya, L; Maio, M; van den Eertwegh, Ajm; Grob, Jj; Gutzmer, R; Jamal, R; Lorigan, P; Ibrahim, N; Marreaud, S; van Akkooi, Acj; Suciu, S; Robert, C |